Skip to main content
MedPathMedPath Home
Clinical Trials/SLCTR/2021/008
SLCTR/2021/008
Not yet recruiting
Phase 2

Randomized double blind placebo controlled trial of the safety and efficacy of investigational herbal preparations for the treatment of patients with COVID-19

niversity of Peradeniya0 sitesTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCOVID 19

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
COVID 19
Sponsor
niversity of Peradeniya
Status
Not yet recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
niversity of Peradeniya

Eligibility Criteria

Inclusion Criteria

  • •1\. Patients who understands and agrees to comply with planned study procedures.
  • •3\. Patients who agree to the collection of nasopharyngeal swabs and venous blood per protocol.
  • •4\. Male \>18 years or non\-pregnant female adult \>18 years of age at the time of enrolement.
  • •5\. Has a laboratory confirmed SARS\-CoV\-2 infection as determined by positive PCR done within 72 hrs, with a quantitative PCR cycle threshold (qPCR Ct value ) which is less than 25 and a positive Rapid antigen testing (RAT) performed at the point of admission.

Exclusion Criteria

  • •1\. Known patients with chronic liver disease and kidney disease
  • •2\. Alanine amino transferase (ALT) or Aspartate amino transferase (AST) or Serum creatinine\> 2 times the upper limit of normal.
  • •3\. Pregnancy or breast feeding.
  • •4\. Anticipated transfer to another hospital which is not a study site within 72 hours.
  • •5\. Allergy to any study medication
  • •6\. Treatment with another investigational drug or other intervention
  • •7\. Patients who are on warfarin, glucocorticoids and other immuno\-suppressive medications or anti\-cancer medications
  • •8\. Patients with known substance abuse

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Trial of combination of polyethylene glycol with or without sodium picosulphate for treatment of constipation in childre
CTRI/2018/01/011262JIPMER intramural grants committee94
Recruiting
Phase 4
Effect of new drugs sodium ozagrel and edaravone in treatment of strokeHealth Condition 1: null- Acute ischaemic Stroke
CTRI/2012/05/002644JIPMER168
Completed
Not Applicable
Randomised double blind placebo controlled trial of calcium supplements in teenage pregnancySigns and Symptoms: Burning Mouth Syndrome (BMS).Signs and SymptomsBurning Mouth Syndrome (BMS).
ISRCTN25268811Record Provided by the NHSTCT Register - 2006 Update - Department of Health15
Completed
Phase 4
Randomised double blind placebo controlled trial on the effect of intraperitoneal ropivacaine on postoperative pain and recovery after diagnostic laparoscopy and hysteroscopy.Post operative pain following day case gynaecological diagnostic laparoscopy and hysteroscopy.Postoperative nausea and vomiting following day case gynaecological diagnostic laparoscopy and hysteroscopyPostoperative recovery following day case gynaecological diagnostic laparoscopy and hysterocopy.Anaesthesiology - Anaesthetics
ACTRN12609000128291Dr Natasha Frawley60
Completed
Not Applicable
Randomised double blind placebo controlled trial of antimicrobial treatment in pregnant women at risk of preterm labourPregnancy and Childbirth: Preterm labourPregnancy and Childbirth
ISRCTN43735180Department of Health (UK)75